Armistice Capital, LLC Hcw Biologics Inc. Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,023,664 shares of HCWB stock, worth $809,465. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,023,664Holding current value
$809,465% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$111,8160.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$72,7820.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$72,3240.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$52,7960.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$30,0460.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.3M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...